INVITATION FOR BIDS
IFB RFx Number: 2025-REQ-198
Mississippi Breast and Cervical Cancer Program - Health
Systems Surveyor/Evidence-Based Intervention Consultant
Issue Date: October 6, 2025
CLOSING TIME AND DATE
Bids must be received before:
5:00 pm CST, November 12, 2025
BID COORDINATOR
Christopher Statham
Telephone: (601) 576-7954
E-mail: procurement@msdh.ms.gov
GENERAL INSTRUCTIONS
Section 1 - Background, Authority, and Purpose
The Mississippi State Department of Health (hereinafter "Agency") has issued this solicitation for the purpose
of soliciting sealed bids from qualified providers to provide Health Systems Survey and Evidence-Based
Intervention Consultation Services. MAGIC RFX # 3160007672
An individual contractor performing in the role of Health Systems Surveyor/Evidence-Based Intervention
Consultant is needed to support the specific, detailed work plan activities of the Mississippi Breast and Cervical
Cancer Program (MS-BCCP) pursuant to Federal Award NU58DP007129. The focus of this procurement is to
identify, evaluate, and implement evidence-based interventions within health systems to enhance breast and
cervical cancer screening and treatment for underserved populations in Mississippi. The consultant will work
with up to three (3) large health systems that provide MS-BCCP paid clinical services to implement evidence-
based interventions (EBIs) that improve service delivery. The consultant will assess and document EBIs selected
for each clinic of the health systems and track clinic-level screening increases and overall success of EBI
implementation.
The Guide to Community Preventive Services has established the following EBIs to increase breast and cervical
cancer screening: client reminders, reducing structural barriers, provider assessment and feedback, provider
reminder and recall systems, engaging community health workers, small media, group education, and one-on-
one education. The Guide recommends the use of multi-component EBIs that combine strategies that increase
community demand for and access to cancer screening.
The consultant will:
• Identify at least one individual within each partnering health system to serve as a champion for EBI
implementation efforts and ensure a cancer screening policy is in place.
• Conduct quality assurance and quality improvement (QA/QI) activities that support the delivery of timely
and appropriate screening and diagnostic services by partnering with MS-BCCP-screening clinics to
conduct a comprehensive assessment and audits of their health care delivery system. Assess the clinic’s
patient process flow, screening practices, and validate the quality of breast and cervical cancer screening
data in electronic health record (EHR) or other data systems, identify established and needed EBIs in
each clinic, and select appropriate interventions for implementation.
• Provide clinic partners with technical assistance (TA) to support EBI implementation, adaptation, and
data monitoring, including reporting of CDC-required clinic-level data.
• Engage organizations with appropriate expertise to assist in providing TA to clinics (e.g., expertise in
clinic workflow or process mapping, assessing clinic readiness to implement EBIs, EBI adaptation and
implementation, quality improvement, use of EHR data for population management, and data
management).
• Engage organizations that demonstrate expertise in and access to the identified populations that are
disproportionately burdened by breast and cervical cancer; ideally these organizations should be in the
communities where women are being served.
• Collect and report clinic-level data on clinic characteristics, screening rates, and EBI implementation
using the CDC-required platform (B&C BARS).
• Provide ongoing communication with key stakeholders of the health systems to reinforce
implementation expectations, assess progress, collect aggregated data, provide feedback, and
encourage continuous quality improvement strategies. This includes email, phone calls, virtual, and in-
person visits.
• Provide semi-annual or annual presentations to the MS-BCCP Stakeholder Group and health systems
partners on assessment and performance of health systems implementing EBIs and receiving
consultation.
Section 2 - Timeline
Invitation for Bid Issue Date:
Bid Package Submission Deadline:
Reconsideration :
October 6, 2025
November 12, 2025, 5:00pm
November 17, 2025
Section 3 - Contact and Questions/Requests for Clarification
3.1 Bidders must carefully review this solicitation, the contract, risk management provisions, and all
attachments for defects, questionable, or objectionable material. Following review, vendors may have
questions to clarify or interpret the IFB in order to submit the best bid possible. To accommodate the
questions and requests for clarifications, vendors shall submit any such question through the Question &
Answer section of this IFB on the Agency's OpenGov Procurement portal by the deadline reflected in
Section 2. All questions and requests for clarifications must be directed through the Agency's portal.
3.2 Official responses will be provided only for questions submitted as described above and only to clarify
information already included in the IFB. The identity of the organization submitting the question(s) will
not be revealed. All questions and answers will be published on the Agency's OpenGov Procurement portal
and released as an addendum to the IFB by the date and time reflected in Section 2.
3.3 The agency will not be bound by any verbal or written information that is not contained within this IFB
unless formally noticed and issued by the contact person as an IFB addendum. Bidders are cautioned that
any statements made by agency personnel that materially change any portion of the bid document shall
not be relied upon unless subsequently ratified by a formal written addendum to the bid document.
3.4 All vendor communications regarding this IFB must be directed through the Agency portal or to the
designated Bid Coordinator. Unauthorized contact regarding the IFB with other employees of the agency
may result in the vendor being disqualified, and the vendor may also be suspended or disbarred from the
State.
3.5 No Pre-Bid Conference, Tour, or Site Visit will be held for this IFB.
3.6 Acknowledgement of Amendments: Should an amendment to the IFB be issued, it will be posted on the
Mississippi Contract/Procurement Opportunity Search Portal website and the agency's website in a
manner that all bidders will be able to view. Further, bidders must acknowledge receipt of any amendment
to the solicitation by signing and returning the amendment with the bid package, by identifying the
amendment number and date in the space provided for this purpose on the bid form, or by letter. The
acknowledgment should be received by the agency by the time, date, and at the place specified for receipt
of bids. It is the bidder’s sole responsibility to monitor the websites for any updates or amendments to
the IFB.
3.7 Bidder must provide a signed Acknowledgements of IFB Amendment(s), Questions and Answer
document(s), and/or Summary of Pre-Bid Conference, Tour, or Site Visit, if any were issued/posted on the
Mississippi Contract/Procurement Opportunity Search Portal website and the agency's website.
3.8 The IFB is comprised of the base IFB document, any attachments, any amendments issued prior to the
submission deadline, and any other documents released before contract award.
Section 4 - Scope of Work
4.1 Scope of Services To Be Performed:
Contractor shall provide services, and otherwise do all things necessary for or incidental to the performance
of work, as set forth below: If you submit a bid response via OpenGov please submit a bid response in MAGIC
under RFX # 3160007672.
A. Initial Health System Assessments: Conduct a comprehensive assessment of existing breast and cervical
cancer screening services and evidence-based interventions employed in participating health systems to
identify gaps and barriers. An initial assessment report of each health system will be due within 45 days
of the contract start date. This will include an assessment of each of the health system's clinic’s patient
process flow, screening practices, validate the quality of breast and cervical cancer screening data in
electronic health record (EHR) or other data systems, identify established and needed EBIs in each clinic
and select appropriate interventions for implementation.
B. Champion Identification/Coaching: Identify at least one individual within each partnering health system
to serve as a champion for EBI implementation efforts and ensure a cancer screening policy is in place
within 45 days of contract start date.
C. Strategic Recommendations: Develop a set of evidence-based recommendations for improving breast
and cervical cancer screening programs based on assessment findings and stakeholder input. Must be
included in the Comprehensive Final Report and presented to the health systems within 180 days of
contract start date.
D. Implementation Plan: Create actionable steps for implementing the recommended interventions,
including timelines and resource allocation. Must be included in the Comprehensive Final Report and
presented to the health systems within 180 days of contract start date.
E. Data Analysis and Data Reporting: Analyze existing data related to screening rates, demographic
disparities, and barriers to screening. This includes quantitative and qualitative methods. Collect and
report clinic-level data on clinic characteristics, screening rates, and EBI implementation using the CDC-
required platform (B&C BARS) annually/semi-annually by deadlines prescribed by CDC. Provide narrative
and qualitative information to be included in MS-BCCP's Annual Performance Report within 120 days of
the contract start date. This information must also be included in the Comprehensive Final Report and
presented to the health systems within 180 days of contract start date.
F. Comprehensive Final Report: A comprehensive final report that includes the assessment results, data
analysis, strategic recommendations, and an implementation plan will be due and presented to each
health system within 180 days of the project start date.
G. Training and Capacity Building: Provide consultation and resources for health system staff regarding
best practices in breast and cervical cancer screening as needed and aligned with recommendations and
implementation plan.
H. Evaluation Framework: Establish a framework for monitoring and evaluating the effectiveness of the
implemented interventions. Provide narrative and qualitative information to be included in MS-BCCP's
Annual Evaluation Executive Summary within 120 days of the contract start date
I. Stakeholder Engagement: Facilitate focus groups and interviews with healthcare providers and other
stakeholders to gather input on current services and barriers to access. A stakeholder engagement
summary report after completing all discussions and interviews will be due within 90 days of the contract
start date. Provide bi-annual presentations to the MS-BCCP Stakeholder Group and health systems
partners on the stakeholder engagement summary report and comprehensive final report findings and
outcomes within 180 days of the contract start date.
J. Communication and Programmatic Reporting: Provide (monthly) ongoing communication with key
stakeholders of the health systems to reinforce implementation expectations, assess progress, collect
aggregated data, provide feedback, and encourage continuous quality improvement strategies. This
This is the opportunity summary page. It provides an overview of this opportunity and a preview of the attached documentation.